Media
Explore our latest news, events, and resources.
From educational publications to campaign highlights and upcoming activities, this section brings together all our updates to keep patients, healthcare professionals, and advocates informed and engaged in the world of radioligand therapy.
News
- News19.08.2021
Health Policy Partnership Framework
Read more - News16.08.2021
PSMA Theranostics: Current Landscape and Future Outlook
Read more - News26.07.2021
July 2021 - The Rising Role of Radiotheranostics
Read more - News01.07.2021
Lu-177-PSMA-617A Added to Standard Therapy
Read more - News01.07.2021
Theranostic Approach in Breast Cancer
Read more - News18.06.2021
FDA for Lu-177-PSMA-617 for mCRPC treatment
Read more
Events
- EventsMarch 10-13, 2023
Meet us at the EAU 2023
Read more - EventsFebruary 27 - March 2, 2023
The 12th International Symposium in Cape Town
Read more - EventsJanuary 19, 2023
The Michael Hofman Masterclass
Read more - EventsOctober 15-19, 2022
EANM 2022
Read more - EventsSeptember 16-18, 2022
36th Brazilian Congress of Nuclear Medicine
Read more - EventsJune 24-26, 2022
6th Theranostics World Congress
Read more
Videos
What Are Radiotheranostics for Cancer Care?
Doctor, will Radiotheranostics make me radioactive?
Tom, treated with PRRT for NETs
Fernando Acosta’s Testimonial with Lutetium-177 PSMA Radioligand Therapy
Links
Nuclear medicine
- The NME (Nuclear medicine Europe) has implemented a website for the general public called “What is Nuclear medicine ?”, that features movies, cartoons and special small booklets to be downloaded that explain basic concepts.
- Official bodies such as EANM and SNMMI also have materials explaining aria-describedby="qtip-67">Nuclear medicine.
- You will find useful information as well on the IAEA website about Radiopharmaceuticals production and some interesting Publications regarding advances search.
Books
In order to explain this technology in an accessible way, a reference booklet containing information on Nuclear medicine was written by the author of this project. It was initially intended for workers in the Radiopharmaceutical industry but was then used for patients and finally distributed to potential investors. This book is presently available in French, English, and Spanish.